Healthcare

Cancer Therapeutics Market by Application (Blood Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Breast Cancer, Cervical Cancer, and Others) and Top Selling Drugs (Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Velcade, Imbruvica, Ibrance, Zytiga, Alimta, Xtandi, Tarceva, Perjeta, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

  • ALL2597639
  • 226 Pages
  • May 2018
  • Healthcare

The use of targeted, biologic (immunotherapy) & other forms of therapies administered to treat cancer through oncology drugs is known as cancer therapeutics. The global cancer therapeutics market was valued at $81,291 million in 2016 and is estimated to reach at $178,863 million by 2023, registering a CAGR of 11.9% from 2017 to 2023.

Upsurge in collaboration between pharmaceutical companies, rise in cancer awareness & availability of oncology drugs, increase in cancer funding & research, and growth in geriatric population are the key factors that augment the growth of the cancer therapeutics market. Furthermore, rise in prevalence of cancer cases is expected to boost the market growth.

However, adverse effects associated with cancer therapeutics market and high costs associated with oncology drug development are some of the factors that impede the market growth. Conversely, the high potential of emerging economies and increase in demand for personalized medicine is expected to provide new opportunities for the market players in future.

The cancer therapeutics market is segmented based on application, top selling drugs, and region. Based on application, the market is divided into blood cancer, lung cancer, colorectal cancer, prostate cancer, breast cancer, cervical cancer, and others. By top selling drugs, it is categorized into Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Velcade, Imbruvica, Ibrance, Zytiga, Alimta, Xtandi, Tarceva, Perjeta, and others. Region wise, it is analyzed across the North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

  • This report entails a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities along with strategic assessment of global cancer therapeutics market.
  • Cancer therapeutics market size and market estimations are based on comprehensive analysis of the applications, top selling drugs, and developments in the industry.
  • An in-depth analysis based on region assists to understand the regional market and facilitate the strategic business planning.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.

KEY MARKET SEGMENTS

By Application

  • Blood Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Breast Cancer
  • Cervical Cancer
  • Others

By Top Selling Drugs

  • Revlimid
  • Avastin
  • Herceptin
  • Rituxan
  • Opdivo
  • Gleevec
  • Velcade
  • Imbruvica
  • Ibrance
  • Zytiga
  • Alimta
  • Xtandi
  • Tarceva
  • Perjeta
  • Others

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle-East
    • Africa

The list of key players operating in this market include:

  • F. Hoffmann-La Roche AG
  • Bristol-Myers Squibb Company
  • AbbVie, Inc.
  • Johnson & Johnson
  • Celgene Corporation
  • Astellas Pharma, Inc.
  • Pfizer, Inc.
  • Novartis AG
  • Merck KGaA
  • Eli Lilly and Company
Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

U.S. NPWT Devices Market - Opportunities and Forecast, 2015 - 2020

Negative Pressure Wound Therapy (NPWT) devices are used to heal wounds by applying sub-atmospheric pressure using sealed dressing connected to vacuum pump. The vacuum source generates negative pressure to remove ...

April 2018| $2850 | Pre Book Price:$2494

Asian Chromatography Solvents Market - Opportunities and Forecasts, 2015 - 2020

Chromatography is a technique used for separation of mixtures for advanced use. Chromatography solvents, such as methanol, chloroform, ethanol, and others are used for separation of mixtures. One component solvent ...

April 2018| $2850 | Pre Book Price:$2494

Intra-Dialytic Hypotension (IDH) Asia-Pacific Market Research Report, 2013 - 2020

Intra-dialytic hypotension (IDH) is defined as a fall in systolic blood pressure by ≥20 mmHg or in mean arterial pressure (MAP) by 10 mmHg correlated with symptoms, which include nausea, ...

April 2018| $2850 | Pre Book Price:$2494

Asia Colonoscopy Devices Market - Opportunities and Forecasts, 2014 - 2020

Colonoscopy devices are used for internal examination of large intestine or colon as well as rectum. These devices come with a small camera connected to a flexible tube. Furthermore, the ...

April 2018| $2850 | Pre Book Price:$2494

European Dermatology Diagnostic Devices Market- Opportunities and Forecasts, 2014 - 2020

The healthcare sector across Europe is witnessing a dramatic shift and is inclined towards less invasive diagnostic procedures. Dermatology diagnostic equipment aids in both easy as well as painless diagnosis. ...

April 2018| $3390 | Pre Book Price:$2967

Asia Pacific Spine Surgery Devices Market - Opportunities and Forecasts, 2015 - 2020

Spine surgery devices are used in surgeries performed for treatment of spinal cord disorders, trauma, bleeding, tumors and others. These devices are used for the treatment of spinal disorders, such ...

April 2018| $2850 | Pre Book Price:$2494

2018 © Copyright Big Market Research

View Pricing >>